BHR Pharma LLC - Company Review
BHR Pharma LLC - Company ReviewSummary
BHR Pharma LLC (BHR), a subsidiary of Besins Healthcare SA is a healthcare services provider that research and develops therapies. The company develops a range of non-oral delivery systems. Its products include include transdermal estradiol gel, progesterone infusion, and afimoxifene gel. BHR’s transdermal system, enhanced hydroalcoholic gel technology and parenteral formulations are used for new product development. It also offers androgel a testosterone replacement therapy. The company’s products are used for the treatment of traumatic brain injury, breast cancer, prostate cancer, breast pain and gynecomastia, among others. BHR is headquartered in Herndon, Virginia, the US.
This comprehensive company report of BHR Pharma LLC provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.